Perspective Therapeutics, Inc. (CATX) Reports In-Line Q3 EPS

Perspective Therapeutics, Inc. (NYSE: CATX) reported Q3 EPS of ($0.21), in-line with the analyst estimate of ($0.21). Revenue for the quarter came in at $369 thousand versus the consensus estimate of $191.73 thousand.

For earnings history and earnings-related data on Perspective Therapeutics, Inc. (CATX) click here.

You May Also Be Interested In

• Trump: Reinstating The Iranian Blockade
• Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
• SpaceX shares continue lower, hit lowest level since IPO